comparemela.com
Home
Live Updates
Final Results Confirm - Breaking News
Pages:
Latest Breaking News On - Final results confirm - Page 1 : comparemela.com
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Final Results Confirm 98% Sustained Virologic Response Rate at Week 4 Post-Treatment from Lead-in Cohort in Phase 2 HCV Study Enrollment in Phase 3 SUNRISE-3 Study Has Surpassed 1,400 COVID-19.
United states
Jean pierre sommadossi
Jonae barnes
While the company
Globenewswire inc
Atea pharmaceuticals
Development expenses
Atea or company
Drug administration
Corporate communications
Program for second generation protease inhibitors
Atea pharmaceuticals inc
See the company
Final results confirm
Sustained virologic response rate
Lead in cohort
vimarsana © 2020. All Rights Reserved.